Engineering of alcohol dehydrogenase 2 hybrid-promoter architectures in Pichia pastoris to enhance recombinant protein expression on ethanol

Ergun B. G. , Gasser B., Mattanovich D., Calik P.

BIOTECHNOLOGY AND BIOENGINEERING, vol.116, no.10, pp.2674-2686, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 116 Issue: 10
  • Publication Date: 2019
  • Doi Number: 10.1002/bit.27095
  • Page Numbers: pp.2674-2686
  • Keywords: alcohol dehydrogenase 2 promoter, Cat8, hybrid-promoter architecture, novel-engineered promoter variant, nucleosome optimization, Pichia pastoris (Komagataella phaffii), synthetic binding site, TRANSCRIPTIONAL ACTIVATOR CAT8P, SYNTHETIC CORE PROMOTERS, DEHYDROGENASE GENE, SEQUENCE, ADR1, IDENTIFICATION, VARIANTS, GLUCOSE, ADH2, SIP4


The aim of this work is to increase recombinant protein expression in Pichia pastoris over the ethanol utilization pathway under novel-engineered promoter variants (NEPVs) of alcohol dehydrogenase 2 promoter (P-ADH2) through the generation of novel regulatory circuits. The NEPVs were designed by engineering of transcription factor binding sites (TFBSs) determined by in silico analyses and manual curation systematically, by (a) single-handedly replacement of specified TFBSs with synthetic motifs for Mxr1, Cat8, and Aca1 binding, and synthetic TATA-box integration; and, (b) nucleosome optimization. PADH2-Cat8-L2 and PADH2-Cat8-L1 designed by the integration of synthetic Cat8 binding sites were superior, and then PADH2-NucOpt. Compared to that with P-ADH2 at t = 20 hr of the fermentations, PADH2-Cat8-L2 allowed the highest increase in enhanced green fluorescent protein expression as 4.8-fold on ethanol and 3.8-fold on methanol; and, PADH2-NucOpt upregulated the expression 1.5-fold on ethanol and enhanced 3.2-fold on methanol. Using the superior two tools, Cat8-L2 and NucOpt, we designed PADH2-NucOpt-Cat8-L2. With PADH2-NucOpt-Cat8-L2, the expression in the fermentation of ethanol was upregulated 3.7-fold that is distinctly higher than that with PADH2-NucOpt but lower than that with PADH2-Cat8-L2; while on methanol compared to that with P-ADH2, the expression was enhanced 8.8-fold. Extracellular recombinant human serum albumin production was also studied with PADH2-Cat8-L2 and PADH2-NucOpt, and average recombinant human serum albumin yield (Y-P/X) on ethanol was 1.13 and 0.38 mg/g(WCW,) respectively; whereas with P-ADH2, Y-P/X was 0.26 mg/g(WCW). We conclude that as upregulation of transcription and enhanced expression correlate with the sequence of synthetic motifs and their location in the hybrid-promoter architectures of NEPVs in coordination with trans-acting factors, which are the design parameters in the engineering of binding sites; the NEPVs generated promising recombinant protein production platforms with a high impact on industrial scale production processes, as well as would open up new avenues for research in P. pastoris.